RecruitingNCT06464159
New Therapeutic Strategy Against Preeclampsia
Studying Preeclampsia
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Principal Investigator
- Vassilis TSASARIS, MD, PhDAssistance Publique - Hôpitaux de Paris
- Intervention
- Biological collection(biological)
- Enrollment
- 100 target
- Eligibility
- 18-50 years · FEMALE
- Timeline
- 2026 – 2028
Study locations (1)
- Maternité Port-Royal, Paris, France
Collaborators
URC-CIC Paris Descartes Necker Cochin
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT06464159 on ClinicalTrials.govOther trials for Preeclampsia
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07199283The PreEclampsia Postpartum Prevention TrialKarolinska Institutet
- RECRUITINGNCT06427408Longitudinal Study of Gene Expression in the Human Placenta During First-trimester and Full-term Pregnancy at the Single Cell LevelAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT07443345Incidence of Postoperative Diaphragmatic Dysfunction in Pregnant Women With PreeclampsiaCairo University
- RECRUITINGNANCT07209254Randomized Controlled Trial of Two Mobile Health Strategies to Manage Postpartum HypertensionJennifer Lewey, MD, MPH
- RECRUITINGNCT07513558Preeclampsia: Origin, Characteristics and Effects on Mother and BabyMedical University of Graz
- RECRUITINGPHASE2NCT06333652Ravulizumab in Pregnancies Complicated by Severe Hypertensive DisordersMayo Clinic
- RECRUITINGNANCT06953115Vagal Stimulation Therapy and PreeclampsiaFundación Internacional René Mey
- RECRUITINGNANCT07193680NOPE37: Angiogenic Factors for Managing Term PreeclampsiaHospital Universitari Vall d'Hebron Research Institute